Verdict89/ 100
Grade B+ · #5Ondra Health
A rare combination: near-cheapest semaglutide, nationwide reach, brand-name access and a LegitScript-verified operation.
Visit Ondra HealthHead-to-head verdict
Ondra Health vs HealthRX
Two GLP-1 providers, ruled side by side on The Verdict Score — our published six-factor rubric. Same yardstick, and no score is adjusted for payment.
vs
Verdict86/ 100
Grade B · #8HealthRX
One of the few names that actually holds a LegitScript certification you can look up — and it pairs that with a rare oral GLP tablet and a fully published plan table, though the headline $99 and $179 rates are 12-month prepay floors, not what a month-to-month patient pays.
Visit HealthRXThe verdict
Winner: Ondra Health
Ondra Health takes it with a higher Verdict Score — 89/100 to 86/100 (grade B+ vs B). Value shoppers who refuse to trade price for legitimacy — the strongest all-around bargain on the board. HealthRX still earns its place — patients who want a verifiable, physician-supervised operator, would rather swallow a daily tablet than inject, and are willing to prepay a year to reach the lowest published rate.
Neither of these is our overall #1. That title goes to CoreAge Rx (94/100) — the most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.
Factor by factor
Both scored on the same six factors — see the methodology. The brass bar marks the stronger side on each.
88Real-world results85
88
Real-world results85
91Price honesty85
91
Price honesty85
91Prescriber access89
91
Prescriber access89
88Formulary choice90
88
Formulary choice90
87Cancellation fairness84
87
Cancellation fairness84
87Member support84
87
Member support84
Price, coverage & features
| Metric | Ondra Health | HealthRX |
|---|---|---|
| Verdict Score | 89/100 | 86/100 |
| Grade | B+ | B |
| Semaglutide | $93/mo | $99/mo (annual) |
| Tirzepatide | $166/mo | $179/mo (annual) |
| Coverage | All 50 states | All 50 states |
| Brand-name access | Yes | Yes |
| Oral / sublingual | No | Yes |
Ondra Health
What we like
- Among the lowest disclosed compounded-semaglutide prices anywhere
- LegitScript-certified with brand-name access on top of compounded
- Available in all 50 states
The caveats
- Tirzepatide is priced higher than its standout semaglutide
- Newer name with a thinner public track record
HealthRX
What we like
- LegitScript-certified (#50087439) — a genuine, checkable trust signal, not a self-claim
- Physician-supervised intake with licensed prescribers
- Carries both molecules plus a rare oral GLP tablet — real route choice
- Full plan table published on-site with a current-as-of date: semaglutide $190/mo month-to-month down to $99/mo on the 12-month plan, tirzepatide $239/mo down to $179/mo — no insurance required
- Cancel online in one click, unshipped doses refunded, 30-day money-back guarantee and a full refund if a provider doesn't approve you
The caveats
- GLP-1 is compounded, not FDA-approved — the standard verification caveat applies
- The advertised $99 and $179 rates require a 12-month prepay — $1,188 and $2,148 up front; month-to-month runs $190 and $239
- Brand Ozempic is pass-through at ~$1,299/mo — the path exists but is priced out of reach for most
Our pick — visit
Value shoppers who refuse to trade price for legitimacy — the strongest all-around bargain on the board.
Visit Ondra Health Read the full Ondra Health review →Also worth a look
Patients who want a verifiable, physician-supervised operator, would rather swallow a daily tablet than inject, and are willing to prepay a year to reach the lowest published rate.
Visit HealthRX Read the full HealthRX review →Keep comparing
Neither of these has to be the answer: the rivals we rank against Ondra Health cover the 7 programmes closest to it, and the same shortlist for HealthRX does the reverse.
Or browse the full comparison hub and the complete rankings.
Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.